What is NDC 31722-089?

31722-089 is the product NDC for Darunavir, Darunavir 800 mg/1 tablet, film coated, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Darunavir?

23 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Darunavir NDC 31722-089 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)31722-089Labeler and product segments. Claims need a package NDC.

Product NDC at billing width31722-0089Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
31722-089-30	3172200893031722008930	30 TABLET, FILM COATED in 1 BOTTLE (31722-089-30)Marketed from Jan 21, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Darunavir
Generic name (nonproprietary): darunavir
Active ingredients: Darunavir — 800 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Camber Pharmaceuticals, Inc.NDC labeler code 31722
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216168
Marketing start: Jan 21, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)HIV Protease Inhibitors (Mechanism)
Identifiers: Product ID 31722-089_30b10990-92c4-531b-e063-6294a90a7a27SPL ID 30b10990-92c4-531b-e063-6294a90a7a27SPL set ID 49606d5e-f45f-45eb-9ab8-15aa6a233875RxCUI 670026, 1359269UNII YO603Y8113
Pharmacologic class: Protease Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N431722008930 followed by a unit qualifier and the quantity

Package 31722-0089-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 19, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Darunavir tablets, co-administered with ritonavir (darunavir tablets/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adult and pediatric patients 3 years of age and older [see Use in Specific Populations (8.4) and Clinical Studies (14)]. Darunavir tablets are a human immunodeficiency virus (HIV-1) protease inhibitor indicated for the treatment of HIV-1 infection in adult and pediatric patients 3 years of age and older. Darunavir tablets must be co-administered with ritonavir (darunavir tablets/ritonavir) and with other antiretroviral agents. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 31722-089

What is NDC 31722-089?: 31722-089 is the product NDC for Darunavir, Darunavir 800 mg/1 tablet, film coated, listed with the FDA by Camber Pharmaceuticals, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Darunavir.
What is the active ingredient?: Darunavir.
Who is the labeler?: Camber Pharmaceuticals, Inc., NDC labeler code 31722. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Darunavir?: 23 other product NDCs are listed under this name. See all Darunavir NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Darunavir NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Darunavir	Darunavir 600 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-088	31722-0088-60
Darunavir	Darunavir dihydrate 800 mg/1	TabletOral	American Health Packaging	60687-819	60687-0819-21
Darunavir	Darunavir dihydrate 600 mg/1	TabletOral	American Health Packaging	60687-808	60687-0808-21
Darunavir	Darunavir 600 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	70771-1745	70771-1745-0570771-1745-0670771-1745-08
Darunavir	Darunavir 800 mg/1	Tablet, Film coatedOral	Zydus Lifesciences Limited	70771-1746	70771-1746-0370771-1746-0570771-1746-09
Darunavir	Darunavir 600 mg/1	Tablet, Film coatedOral	Viona Pharmaceuticals Inc	72578-147	72578-0147-0572578-0147-1472578-0147-28
Darunavir	Darunavir 800 mg/1	Tablet, Film coatedOral	Viona Pharmaceuticals Inc	72578-148	72578-0148-0572578-0148-0672578-0148-16
darunavirdarunavir 600 mg	Darunavir hydrate 600 mg/1	TabletOral	EXELAN PHARMACEUTICALS INC.	76282-737	76282-0737-60
darunavirdarunavir 800 mg	Darunavir hydrate 800 mg/1	TabletOral	EXELAN PHARMACEUTICALS INC.	76282-738	76282-0738-30
Darunavir	Darunavir 600 mg/1	Tablet, Film coatedOral	Amneal Pharmaceuticals NY LLC	60219-1144	60219-1144-06

All 24 Darunavir NDCs

Other NDCs under ANDA 216168

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216168
Product	Strength	Form · route	Labeler	Product NDC
Darunavir	Darunavir 600 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-088